BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

913 related articles for article (PubMed ID: 25400741)

  • 1. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
    Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
    Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
    J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways.
    Cho HI; Hong JM; Choi JW; Choi HS; Hwan Kwak J; Lee DU; Kook Lee S; Lee SM
    Eur J Pharmacol; 2015 Oct; 764():613-621. PubMed ID: 26254779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic effect of CORM-3 on acute liver failure induced by lipopolysaccharide/D-galactosamine in mice.
    Yan BZ; Yang BS; Li H; Zhang YF; Pei FH; Zhu AC; Wang XR; Liu BR
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):73-80. PubMed ID: 26818546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyrrhetinic acid attenuates lipopolysaccharide-induced fulminant hepatic failure in d-galactosamine-sensitized mice by up-regulating expression of interleukin-1 receptor-associated kinase-M.
    Yin X; Gong X; Zhang L; Jiang R; Kuang G; Wang B; Chen X; Wan J
    Toxicol Appl Pharmacol; 2017 Apr; 320():8-16. PubMed ID: 28213090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM
    Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
    Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
    Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
    J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPS pretreatment ameliorates D-galactosamine/lipopolysaccharide-induced acute liver failure in rat.
    Dong JZ; Wang LP; Zhang SN; Shi KQ; Chen SL; Yang NB; Ni SL; Zhu JH; Lu MQ
    Int J Clin Exp Pathol; 2014; 7(11):7399-408. PubMed ID: 25550775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
    Tao YC; Wang ML; Wu DB; Luo C; Tang H; Chen EQ
    J Transl Med; 2019 May; 17(1):151. PubMed ID: 31077206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1.
    Yang NB; Ni SL; Li SS; Zhang SN; Hu DP; Lu MQ
    Int J Clin Exp Pathol; 2015; 8(8):9062-71. PubMed ID: 26464648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway.
    Zhang Z; Tian L; Jiang K
    Int Immunopharmacol; 2019 Dec; 77():105974. PubMed ID: 31735662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice.
    Ma L; Gong X; Kuang G; Jiang R; Chen R; Wan J
    Biochem Biophys Res Commun; 2015 May; 461(2):230-6. PubMed ID: 25866179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neohesperidin dihydrochalcone down-regulates MyD88-dependent and -independent signaling by inhibiting endotoxin-induced trafficking of TLR4 to lipid rafts.
    Xia X; Fu J; Song X; Shi Q; Su C; Song E; Song Y
    Free Radic Biol Med; 2015 Dec; 89():522-32. PubMed ID: 26453923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
    Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
    Kang JW; Kim DW; Choi JS; Kim YS; Lee SM
    Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
    Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
    Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of the pretreatment and treatment with RhIL-11 on acute liver failure induced by D-galactosamine.
    Nie XH; Han T; Ha FU; Liang N; Wang SH; Zhu ZY; Xiang HL
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1142-50. PubMed ID: 24817287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoliquiritigenin alleviates LPS/ D-GalN-induced acute liver failure by activating the PGC-1α/ Nrf2 pathway to reduce oxidative stress and inflammatory response.
    Wang L; Wang X; Kong L; Wang S; Huang K; Wu J; Wang C; Sun H; Liu K; Meng Q
    Int Immunopharmacol; 2021 Nov; 100():108159. PubMed ID: 34555641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.